NEW YORK, Oct. 23 - Incyte Genomics and Genentech have struck a licensing deal that covers patents covering therapeutic antibodies to four proteins discovered by Incyte, the companies said on Tuesday.

Under terms of the agreement, Incyte is entitled to receive clinical development milestone payments for the antibodies and royalties if any are commercialized.

Financial terms of the agreement and the intended clinical uses of the four antibodies were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times profiles 23andMe's Anne Wojcicki and describes how she bounced back from a bad year.

Fotis Kafatos, the founding president of the European Research Council, has died, according to the Associated Press.

In PLOS this week: genomic analysis of honeybee disease, microRNA profiles of people with lupus nephritis, and more.

The Verge's Angela Chen tried out a gene test for fitness advice, but didn't learn much new information.